Our team will be unavailable from December 25, 2023, to January 1, 2024.
We will resume operations on January 2, 2024. Wishing you a joyful holiday season!

David Husman Launches Quality & Compliance Consulting Company

Dr. David Husman has launched David Husman Consulting, LLC, a company that assists manufacturers with quality and compliance within the pharmaceutical, biopharmaceutical, and biotech industries. Services include quality program development, compliance auditing, remediation, and training.

Serving as president and principal consultant of the company, Dr. Husman holds a doctorate degree in biochemistry and has more than 30 years of diverse international experience in quality assurance, quality control, and regulatory affairs within the pharmaceutical, biopharmaceutical, and biotech industries. Before beginning David Husman Consulting, he was a principal consultant with Parexel Consulting. He also has served previously in leadership roles in quality assurance, quality control, and regulatory affairs.  

Dr. Husman is certified in Good Manufacturing Practices and regulatory affairs. He earned his doctorate and bachelor’s degree in biochemistry from The Ohio State University in Columbus, Ohio. He is a long-term member of various professional organizations, including the Regulatory Affairs Professional Society, Parenteral Drug Association, American Society for Quality, and the S.C. Biotechnology Innovation Organization.

David Husman Consulting began accepting clients as of February 1, 2020. For more information, visit DavidHusmanConsulting.com. 

Join now to enjoy expanded member benefits!

Enjoy exclusive member content, special events, savings, networking and more

Tamia Sumpter

Tamia is a driven senior undergraduate Bioengineering student currently enrolled at Clemson University. With a strong foundation in her field, she has honed her skills through hands-on experience in research and development at Eli Lilly & Company. During her time in the ADME department, Tamia contributed significantly by working on siRNAs and their applications in finding In Vitro-In Vivo Correlation (IVIVC). Looking ahead, Tamia has set her sights on a promising career in law. She aspires to specialize in Intellectual Property Law, with a particular focus on serving as in-house counsel for leading medical device or pharmaceutical companies. Her enthusiasm for this role is palpable as she prepares to embark on her legal journey! She is also a proud member of the Omicron Phi chapter of Delta Sigma Theta Sorority, Inc., PEER Mentor for Clemson PEER/WiSE, and currently serves as the President of Clemson Bioengineering Organization (CBO). With her unique blend of scientific knowledge and legal interests, Tamia is poised to make a meaningful impact in the healthcare and life sciences industries.